Lost Money on Voyager Therapeutics, Inc. (VYGR)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Voyager Therapeutics, Inc. (NASDAQ:VYGR) for potential federal securities law violations. This follows Voyager's announcement about issues with its gene therapy program for ALS, specifically concerning the siRNA payload component of VY9323.
February 21, 2025 | 2:30 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Voyager Therapeutics is under investigation by Levi & Korsinsky for potential securities law violations. The investigation follows Voyager's announcement of issues with its ALS gene therapy program, which may impact investor confidence.
The investigation by Levi & Korsinsky into potential securities law violations is significant, as it may lead to legal consequences and affect investor confidence. The issues with the ALS gene therapy program further compound the negative sentiment, likely impacting VYGR's stock price negatively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100